A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects

Eunwoo Kim,1 Kyoung Ryun Park,1 In-Jin Jang,1 Kyung-Sang Yu,1 SeungHwan Lee1,2 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea; 2Clinical Trials Center, Seoul National University Hospital, Seoul, Republic of...

Full description

Bibliographic Details
Main Authors: Kim E, Park KR, Jang IJ, Yu KS, Lee S
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:Drug Design, Development and Therapy
Subjects:
dpp-4 inhibitor
statin
type 2 diabetes
dyslipidemia
pharmacokinetics
Online Access:https://www.dovepress.com/a-fixed-dose-combination-of-gemigliptin-and-rosuvastatin-exhibits-simi-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/a-fixed-dose-combination-of-gemigliptin-and-rosuvastatin-exhibits-simi-peer-reviewed-article-DDDT

Similar Items